Lucid Diagnostics Inc.
LUCD
$1.20
-$0.01-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.20M | 1.17M | 976.00K | 1.00M | 1.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20M | 1.17M | 976.00K | 1.00M | 1.04M |
| Cost of Revenue | 2.10M | 1.68M | 1.61M | 1.66M | 1.43M |
| Gross Profit | -906.00K | -512.00K | -638.00K | -655.00K | -388.00K |
| SG&A Expenses | 9.65M | 9.41M | 9.08M | 8.26M | 8.49M |
| Depreciation & Amortization | 222.00K | 105.00K | 105.00K | 155.00K | 629.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.47M | 12.87M | 12.17M | 11.79M | 12.49M |
| Operating Income | -12.28M | -11.69M | -11.19M | -10.79M | -11.45M |
| Income Before Tax | -11.54M | -12.37M | -11.01M | -10.61M | -10.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.54M | -12.37M | -11.01M | -10.61M | -10.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.54M | -12.37M | -11.01M | -10.61M | -10.83M |
| EBIT | -12.28M | -11.69M | -11.19M | -10.79M | -11.45M |
| EBITDA | -12.05M | -11.48M | -10.96M | -10.29M | -10.83M |
| EPS Basic | -0.20 | -0.25 | -0.23 | -0.40 | -0.26 |
| Normalized Basic EPS | -0.08 | -0.14 | -0.14 | -0.15 | -0.16 |
| EPS Diluted | -0.20 | -0.25 | -0.23 | -0.40 | -0.26 |
| Normalized Diluted EPS | -0.08 | -0.14 | -0.14 | -0.15 | -0.16 |
| Average Basic Shares Outstanding | 58.38M | 50.37M | 48.21M | 45.01M | 42.33M |
| Average Diluted Shares Outstanding | 58.38M | 50.37M | 48.21M | 45.01M | 42.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |